These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 15465833)

  • 1. Aldose reductase-catalyzed reduction of aldehyde phospholipids.
    Srivastava S; Spite M; Trent JO; West MB; Ahmed Y; Bhatnagar A
    J Biol Chem; 2004 Dec; 279(51):53395-406. PubMed ID: 15465833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substrate specificity and catalytic efficiency of aldo-keto reductases with phospholipid aldehydes.
    Spite M; Baba SP; Ahmed Y; Barski OA; Nijhawan K; Petrash JM; Bhatnagar A; Srivastava S
    Biochem J; 2007 Jul; 405(1):95-105. PubMed ID: 17381426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of aldose reductase in the metabolism of atherogenic aldehydes.
    Srivastava S; Liu SQ; Conklin DJ; Zacarias A; Srivastava SK; Bhatnagar A
    Chem Biol Interact; 2001 Jan; 130-132(1-3):563-71. PubMed ID: 11306075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reductive metabolism increases the proinflammatory activity of aldehyde phospholipids.
    Vladykovskaya E; Ozhegov E; Hoetker JD; Xie Z; Ahmed Y; Suttles J; Srivastava S; Bhatnagar A; Barski OA
    J Lipid Res; 2011 Dec; 52(12):2209-2225. PubMed ID: 21957201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural and kinetic determinants of aldehyde reduction by aldose reductase.
    Srivastava S; Watowich SJ; Petrash JM; Srivastava SK; Bhatnagar A
    Biochemistry; 1999 Jan; 38(1):42-54. PubMed ID: 9890881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants of bioactivity of oxidized phospholipids. Specific oxidized fatty acyl groups at the sn-2 position.
    Subbanagounder G; Leitinger N; Schwenke DC; Wong JW; Lee H; Rizza C; Watson AD; Faull KF; Fogelman AM; Berliner JA
    Arterioscler Thromb Vasc Biol; 2000 Oct; 20(10):2248-54. PubMed ID: 11031211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uptake and protein targeting of fluorescent oxidized phospholipids in cultured RAW 264.7 macrophages.
    Stemmer U; Ramprecht C; Zenzmaier E; Stojčić B; Rechberger G; Kollroser M; Hermetter A
    Biochim Biophys Acta; 2012 Apr; 1821(4):706-18. PubMed ID: 22333180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective recognition of glutathiolated aldehydes by aldose reductase.
    Ramana KV; Dixit BL; Srivastava S; Balendiran GK; Srivastava SK; Bhatnagar A
    Biochemistry; 2000 Oct; 39(40):12172-80. PubMed ID: 11015195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the glutathione binding site of aldose reductase.
    Ramana KV; Dixit BL; Srivastava S; Bhatnagar A; Balendiran GK; Watowich SJ; Petrash JM; Srivastava SK
    Chem Biol Interact; 2001 Jan; 130-132(1-3):537-48. PubMed ID: 11306073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetic and structural characterization of the glutathione-binding site of aldose reductase.
    Dixit BL; Balendiran GK; Watowich SJ; Srivastava S; Ramana KV; Petrash JM; Bhatnagar A; Srivastava SK
    J Biol Chem; 2000 Jul; 275(28):21587-95. PubMed ID: 10764810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydroxy alkenal phospholipids regulate inflammatory functions of endothelial cells.
    Subbanagounder G; Deng Y; Borromeo C; Dooley AN; Berliner JA; Salomon RG
    Vascul Pharmacol; 2002 Apr; 38(4):201-9. PubMed ID: 12449016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aldose reductase decreases endoplasmic reticulum stress in ischemic hearts.
    Keith RJ; Haberzettl P; Vladykovskaya E; Hill BG; Kaiserova K; Srivastava S; Barski O; Bhatnagar A
    Chem Biol Interact; 2009 Mar; 178(1-3):242-9. PubMed ID: 19041636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of cardiac oxidoreductase(s) involved in the metabolism of the lipid peroxidation-derived aldehyde-4-hydroxynonenal.
    Srivastava S; Chandra A; Ansari NH; Srivastava SK; Bhatnagar A
    Biochem J; 1998 Feb; 329 ( Pt 3)(Pt 3):469-75. PubMed ID: 9445372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aldose reductase protects against early atherosclerotic lesion formation in apolipoprotein E-null mice.
    Srivastava S; Vladykovskaya E; Barski OA; Spite M; Kaiserova K; Petrash JM; Chung SS; Hunt G; Dawn B; Bhatnagar A
    Circ Res; 2009 Oct; 105(8):793-802. PubMed ID: 19729598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toxicity of oxidized phospholipids in cultured macrophages.
    Stemmer U; Dunai ZA; Koller D; Pürstinger G; Zenzmaier E; Deigner HP; Aflaki E; Kratky D; Hermetter A
    Lipids Health Dis; 2012 Sep; 11():110. PubMed ID: 22958747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Catalytic reduction of carbonyl groups in oxidized PAPC by Kvβ2 (AKR6).
    Xie Z; Barski OA; Cai J; Bhatnagar A; Tipparaju SM
    Chem Biol Interact; 2011 May; 191(1-3):255-60. PubMed ID: 21296056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of biochemical pathways for the metabolism of oxidized low-density lipoprotein derived aldehyde-4-hydroxy trans-2-nonenal in vascular smooth muscle cells.
    Srivastava S; Conklin DJ; Liu SQ; Prakash N; Boor PJ; Srivastava SK; Bhatnagar A
    Atherosclerosis; 2001 Oct; 158(2):339-50. PubMed ID: 11583712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure of a glutathione conjugate bound to the active site of aldose reductase.
    Singh R; White MA; Ramana KV; Petrash JM; Watowich SJ; Bhatnagar A; Srivastava SK
    Proteins; 2006 Jul; 64(1):101-10. PubMed ID: 16639747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition kinetics of human kidney aldose and aldehyde reductases by aldose reductase inhibitors.
    Bhatnagar A; Liu SQ; Das B; Ansari NH; Srivastava SK
    Biochem Pharmacol; 1990 Mar; 39(6):1115-24. PubMed ID: 2157439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolism of the 2-oxoaldehyde methylglyoxal by aldose reductase and by glyoxalase-I: roles for glutathione in both enzymes and implications for diabetic complications.
    Vander Jagt DL; Hassebrook RK; Hunsaker LA; Brown WM; Royer RE
    Chem Biol Interact; 2001 Jan; 130-132(1-3):549-62. PubMed ID: 11306074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.